MAIA Biotechnology is a targeted therapy, immune-oncology company, focused on development and commercialization of first-in-class drugs with novel mechanisms of action that are intended to meaningfully improve and extend the lives of people with cancer.
A publicly traded company based in Chicago, MAIA (NYSE American: MAIA) is led by a passionate, principled and highly experienced Management Team with significant drug development experience, committed to advancing promising agents into human clinical trials.
MAIA’s business strategy is designed to advance a strong value proposition for its portfolio of potentially novel compounds. MAIA controls risk and enhances its opportunity for success by diversifying and generating this portfolio of assets with a variety of compounds with novel mechanisms of action which have potential activity in multiple tumor types.
MAIA’s business model involves placing drug candidates in their own dedicated, R&D focused subsidiary company, which is supported by the common infrastructure, management team, and resources of the MAIA enterprise. This model allows MAIA to provide more focused R&D support to each drug candidate, while also distributing shared central resources among subsidiary companies to maintain a lean, capital-efficient operating structure.
Company Details
- Employees
- 26
- Founded
- 2018
- Address
- 444 West Lake Street,
- Industry
- Biotechnology
- Website
- maiabiotech.com
- Keywords
- Drug development, Oncology, Research, Targeted Therapy, Immmuno-Oncology, Telomere Targeting, Biotechnology, Small Molecule, Pharmaceutical, Immunotherapy.
- HQ
- Chicago, Illinois
Maia Biotechnology, Inc. Questions
Maia Biotechnology, Inc.'s website is maiabiotech.com
Maia Biotechnology, Inc.'s LinkedIn profile is https://www.linkedin.com/company/maiabiotech
Maia Biotechnology, Inc. has
26 employees.
View email and phone details for 26
employees at Maia Biotechnology, Inc..
Maia Biotechnology, Inc.'s industry is
Biotechnology
Maia Biotechnology, Inc.'s top competitors are
Vanqua Bio,
Evozyne,
Exicure,
Grove Biopharma, Inc.,
Xeris Pharmaceuticals, Inc.,
Genz Biotechnology,
Maia Pharmaceuticals,
Paragon Biosciences,
Circ Biosciences,
Emalex Biosciences.
Maia Biotechnology, Inc.'s categories are Biotechnology
Maia Biotechnology, Inc.'s founding year is 2018
